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Abstract
Background It has already been more than 50 years since
the Pavlik harness was introduced in Japan, and today the
Pavlik harness is widely recognized as the standard initial
treatment modality for developmental dysplasia of the hip.
We performed a multicenter nationwide questionnaire
study concerning the results of Pavlik harness treatment
twice in 1994 and 2008.
Methods In 1994 and in 2008, we sent questionnaires to
12 institutes in Japan specializing mainly in pediatric
orthopedics. We compare the results of these two studies
and discuss differences in reduction rates, incidence of
avascular necrosis in the femoral epiphysis and the per-
centage of joints with acceptable morphology (Severin
grade I ? II/total) at skeletal maturity. We statistically
assessed these results to see whether there were changes in
the treatment outcomes over this 14-year period.
Results Reduction of the dislocated hips was obtained
by the Pavlik harness in 80.2 % (1990/2481 hips; 1994)
and 81.9 % (1248/1523 hips; 2008). The incidences of
avascular necrosis of the proximal femoral epiphysis in
the dysplastic hips were 14.3 % (119/835 hips; 1994) and
11.5 % (76/663 hips; 2008). The type of avascular
necrosis in hips from the 2008 study was determined
according to the classification of Kalamchi and MacEwen:
24/69 hips (34.8 %) were classified as group I; 20/69 hips
(29.0 %) as group II; 11/69 hips (15.9 %) as group Ill;
14/69 hips (20.3 %) as group IV. The percentages of hips
with acceptable outcomes at skeletal maturity discerned
from Severin X-ray changes (grade I ? II/total) were
72.3 % (604/835 hips; 1994) and 77.7 % (488/628 hips;
2008).
Conclusion Reduction rates and the incidence of avas-
cular necrosis in 2008 were statistically similar to the
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results in 1994. The rate of acceptable outcome (Severin
grade I ? II/total) in 2008 was statistically higher than that
of 1994.
Introduction
Arnold Pavlik began to develop a functional harness for the
management of developmental dysplasia of the hip in 1944,
and Pavlik and his co-workers [1] presented the theory and
their methods for the first time at the conference of the
Czechoslovakian Society for Orthopedic Surgery and
Traumatology in Prague in 1946. Pavlik harness treatment
was introduced to Japan before 1960. Today the Pavlik
harness has already gained widespread use throughout the
world including Japan for the treatment of developmental
dysplasia of the hip. The Pavlik harness induces sponta-
neous abduction of hips and a decrease in adductor muscle
tone, leading to the gentle and spontaneous reduction and
stabilization of the dislocated hip joints. If this harness is
properly applied, a high ratio of hip reduction can be
expected with a low complication rate. Previous reports
have documented the favorable success rates of Pavlik
harness treatment for developmental dysplasia of the hip.
In a well-known study in Japan, Suzuki [2] reported a
success rate of 182/216 hips (84.2 %) with 9 showing some
residual deformity of the femoral head.
When hip reduction fails under Pavlik harness treat-
ment, the hips usually require other treatment methods,
such as manipulation under anesthesia and immobiliza-
tion in a cast. These treatments result in an increased rate
of avascular necrosis of the proximal femoral epiphysis
[3, 4].
One of the most important review articles addressing the
treatment of developmental dysplasia of the hip using the
Pavlik harness was the publication in 1988 of the results of
a comprehensive multicenter study of the European pedi-
atric orthopaedic society by Grill and co-workers. They
assessed the results of treatment of 3611 hips in 2636
children [5]. The children in this report were treated during
the period 1976–1986 and followed from 1 to 8.9 years.
The average age at the time of the initial treatment was
4.1 months (range 2 days to 11 months). In Grill’s report,
treatment with the Pavlik harness achieved normal hips in
95.35 % of patients with dysplastic hips and 80 % of
patients with dislocated hips. Overall, 92 % of all dislo-
cated hips were reduced in the Pavlik harness, while the
total rate of avascular necrosis of the proximal femoral
epiphysis was 2.38 %.
In 1994 and in 2008, we sent questionnaires to multiple
pediatric orthopedic institutions nationwide. Our points of
interest were the reduction rate and incidence of avascular
necrosis of the femoral epiphysis, and in children followed
to skeletal maturity at age 14 years, the X-ray outcomes.
We believe these statistical data should be an important
benchmark for the treatment of dysplastic hips using the
Pavlik harness.
Patients and methods
First in 1994 and then in 2008, we sent questionnaires to 12
institutes in Japan specializing mainly in pediatric ortho-
pedics. We requested data concerning children treated with
the Pavlik harness for developmental dysplasia of the hip.
Reduction rates, incidence of avascular necrosis in the
femoral epiphysis and long-term outcomes were tabulated.
Only hips with complete dislocations were included. For
those children who had reached skeletal maturity (age
14 years), Severin grades were requested. Patients who
underwent surgical procedures such as osteotomies were
excluded. At the 12 institutions, a total of 2481 hips were
initially treated with the Pavlik harness for dislocation in
1994, and 1523 hips were treated in this way in 2008.
Accurate assessment of avascular necrosis was available
for 835 hips in 1994 and 663 hips in 2008. Among those
joints, 835 were followed to skeletal maturity and Severin
grouping in 1994, with 628 hips similarly followed up in
2008.
Diagnosis of avascular necrosis was established from
X-ray findings. In addition, hips displaying avascular
necrosis of the femoral heads in 2008 were classified
according to the classification of Kalamchi and MacE-
wen [6]: group I hips had changes affecting the ossific
nucleus, group Il hips had lateral physeal damage, group
III hips had central physeal damage, and group IV hips
had damage to the entire femoral head and physis. Hips
that were followed up to 14 years of age were evaluated
according to Severn’s criteria as modified by Kasser
et al. [7].
For the totaled results of multiple institutes in Japan,
we made statistical analyses using the chi-square test
concerning success rates of reduction by the Pavlik
harness treatment between the two results in 1994 and
2008. We also made the same statistical analysis on the
incidence of avascular necrosis of the femoral head and
the rate of acceptable Severin X-ray changes (group I
and II). Statistical significance was defined as a p value
\0.05.
Ethics statement
This study was approved by the institutional review board
of Nagoya City University Graduate School of Medical
Sciences according to the ethical guidelines for epidemi-
ology research (approval no. 772).
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Results
The average age of the patients at the initiation of treatment
was more than 3 months after birth in all institutions (range
3.5–4.8 months).
The reduction rates for the dislocated hips were 80.2 %
(1990/2481 hips; 1994) and 81.9 % (1248/1523 hips;
2008). These results showed no statistically significant
difference; p = 0.05 (Table 1).
The incidence of avascular necrosis of the proximal
femoral epiphysis was 14.3 % (119/835 hips; 1994) and
11.5 % (76/663 hips; 2008). These results were also not
significantly different; p = 0.05 (Table 2).
Classification of the type of avascular necrosis
according to Kalamchi and MacEwen [6] was possible
for 69 hips in 2008: 24/69 hips (34.8 %) were classified
as group I, 20/69 hips (29.0 %) as group II, 11/69 hips
(15.9 %) as group III and 14/69 hips (20.3 %) as group
IV (Table 3).
The percentages of hips with acceptable X-ray outcomes
at skeletal maturity (Severin grade I ? II/total) were
72.3 % (604/835 hips; 1994) and 77.7 % (488/628 hips;
2008). Statistically, outcomes were better in 2008 than in
1994; p \ 0.05 (Table 4).
Discussion
Arnold Pavlik published 5 articles about his harness, its
principles and his results from 1950 to 1959. He first
reported the effectiveness of his orthotic device constructed
of leather straps in 1950 [8, 9]. His most famous article was
reported in the Zeitschrift fur Ortopaedie in 1957 [3], and
this article was translated by Peltier [4]. He reported the
results of 1912 hips (640 dysplasias, 640 subluxations and
632 dislocations) in 1424 children functionally treated with
the Pavlik harness. He reported that no spontaneously
reduced hips developed avascular necrosis of the femoral
head. However, hips not spontaneously reduced were
treated with passive-mechanical manipulation, and avas-
cular necrosis occurred in 18 hips.
His article in 1959 was entitled ‘‘To the question of
originality of treatment of congenital dysplasias of the hip
joint by active movements in the stirrups’’ [10, 11]. In this
article, he suggested that the main condition for success is
the early start of treatment, preferably no later than 8 to 9
postnatal weeks.
Reasons for the failure of reduction in the Pavlik harness
have been addressed by many investigators. Some have
proposed a close relationship between age at initiation of
treatment and the success rate of spontaneous reduction of
dislocated hips. All of them have suggested that the earlier
the treatment is started, the better results can be achieved.
Viere and co-workers [12] reported that a child aged more
than 7 weeks at initial treatment ran a significantly
increased risk of failure for the stable reduction of hips.
Harding and co-workers showed that the age at initiation of
treatment influences the outcome of a 3-week trial of
Pavlik harness treatment for reduction. They reported that
infants who started the treatment with the harness after the
age of 3 weeks had a higher failure rate (80 %) compared
with those seen earlier (36 %) [13]. Atalar and co-workers
reported that a statistical difference was found between
successful and unsuccessful Pavlik harness treatment for
the reduction of hips in terms of the infants’ age at the start
of treatment. Infants aged 7 weeks and under had a higher
rate of success than those aged 8 weeks and over [14].
Several investigators in Europe have also pointed out a
close relationship between age at initiation of treatment and
incidence of avascular necrosis of the proximal femoral
epiphysis. In Grill’s report, statistical analysis showed that
if the treatment was started within the first 3 months of life,
the rate of avascular necrosis was markedly suppressed.
The rate of avascular necrosis of the proximal femoral
epiphysis was 50 % lower in these children than that in
those who started treatment between the third and sixth
months of life [5]. Kruczynski found that if treatment was
started after the sixth month of life, the appearance of
avascular necrosis of the proximal femoral epiphysis in the
Table 1 Reduction rate
Years Hips Reduction rate % Chi-square test
1994 2481 1990/2481 80.2 v2 = 1.834
2008 1523 1248/1523 81.9 NS p = 0.05
Table 2 Avascular necrosis of the proximal femoral epiphysis
Years Hips AVN % Chi-square test
1994 835 119/835 14.3 v2 = 2.538
2008 663 76/663 11.5 NS p = 0.05
Table 3 The classification of Kalamchi and MacEwen











Table 4 Sufficient rate for Severin grade (I ? II/total)
Years Hips Severin I ? II/total % Chi-square test
1994 835 604/835 72.3 v2 = 5.464
2008 628 488/628 77.7 2008 [ 1994 p \ 0.05
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affected hip was significantly high [15]. Pap and co-
workers [16] grouped their patients according to the ages at
the start of treatment, and they found a close relationship
between age and incidence of avascular necrosis of the
proximal femoral epiphysis on the dysplastic side.
However, some investigators have suggested that there
was no significant relationship between the patients’ age at
initiation of treatment and either the reduction rate of
dislocated hips or the incidence of avascular necrosis.
Lerman and co-workers [17] reported a statistical analysis
on treatment effects with emphasis on the patients’ age at
initiation of treatment, and no significant difference could
be found. Suzuki and co-workers reported that the severity
of the avascular necrosis had no relationship to the
patient’s age at the beginning of treatment [18]. Kitoh and
co-workers [19] reported that age had no statistical rela-
tionship with the failure of reduction and the incidence of
avascular necrosis.
What then is the optimum age for treatment in the Pavlik
harness? Currently, there is no clear answer to this
question.
The mean age at initiation of Pavlik harness treatment at
the 12 institutions participating in this study ranged from
3.5 to 4.8 months. In Japan, the majority of dysplastic hips
are discovered in screening programs usually performed at
3 or 4 months of age. This may account for the relatively
delayed initiation of treatment in this country. Also, many
pediatric orthopedic surgeons have harbored the belief that
very young patients may be more susceptible to the more
severe types of avascular necrosis that lead to poor long-
term outcomes. Whether this is true is also a question that
requires clarification. There is a well-known study by
Iwasaki of Nagasaki University School of Medicine [20].
Between 1966 and the first half of 1976, he treated 240
completely dislocated hips in 204 patients by using the
Pavlik harness. The age of patients at the start of treatment
ranged between 1 and 7 months. In Iwasaki’s investigation,
reduction was achieved in 82.7 % of the children who were
between 31 and 60 days at the beginning of the treatment.
When the treatment began between 91 and 120 days of age,
the reduction rate was an even better 91.1 %. Concerning
avascular necrosis of the femoral head, it occurred in
13.6 % in the patients who started treatment by Pavlik
harness between 31 and 60 days old, while only 6.3 % of
patients whose initial treatment age was between 91 and
120 days after birth had avascular necrosis. From this
evidence, it would seem that the optimum age for initiation
of Pavlik harness treatment should be after reaching
91 days old, 3 months after birth in Japan. Overall the
therapeutic results of this study are quite comparable with
the results of the multicenter study of the European Pedi-
atric Orthopaedic Society by Grill and co-workers [5].
However, differences in the patient population should be
discussed. Grill and co-workers evaluated the reduction
rate and avascular necrosis of the proximal femoral
epiphysis according to the To¨nnis grade. In the present
study, we only addressed hips with complete dislocations,
corresponding to To¨nnis grade 3 and 4. In the multicenter
study of Grill and co-workers, treatment with the Pavlik
harness achieved reduction in 80 % of patients with dis-
located hips. This rate was similar to our results, 80.2 %
(1994) and 81.9 % (2008). Grill and co-workers in 1988
demonstrated that the rate of avascular necrosis with the
Pavlik harness was 3.1 % in To¨nnis grade 3 and 16.4 % in
To¨nnis grade 4. Our data on the incidence of avascular
necrosis of the proximal femoral epiphysis for combined
To¨nnis grade 3 and 4 hips was 14.3 % in 1994 and 11.5 %
in 2008. When comparing these European and Japanese
results, racial difference could be another factor influencing
outcome. It is reassuring to note that no major differences
were observed.
Reduction rates and the incidence of avascular necrosis
in the 2008 multicenter study were statistically similar to
the results collected in 1994. However, the rate of
acceptable outcome (Severin grade I ? II/total) in 2008
was statistically higher than that in 1994.
We believe that the results of this study provide impor-
tant insight into the present status of Pavlik harness therapy
in our country. Application techniques for the harness were
established by our forerunners more than 30 years ago, as
shown by the unchanged reduction rates and unaltered
incidence of avascular necrosis. Furthermore, statistically
improved long-range outcomes could indicate that ongoing
attention to treatment details are proving to be effective.
One contributing factor to improved treatment outcomes
over our study period could be the growing use of ultraso-
nography. Although physical examination is still the main
tool in the diagnosis of infantile hip dislocation, many
institutions now utilize ultrasonographic screening tech-
niques, leading to improved diagnostic accuracy. In addi-
tion, ultrasonography is now used as a tool to monitor the
progress of treatment with the Pavlik harness, usually
through the anterior probing approach [21]. Attention to the
details of Pavlik harness application has also led to better
long-term results. Since the dangers of excessive abduction
under the Pavlik harness have been reported [22], many
institutions are using pillows or special supporting cushions
to prevent this [20]. The Pavlik harness has now been the
accepted initial treatment for infantile dislocated hips in
Japan for many decades, with consistently satisfactory
results in the majority of cases.
The rates of reduction in completely dislocated hips, the
incidence of avascular necrosis complications and Severin
X-ray changes in this report should be a bench mark for
those undertaking treatment of the child’s hip with the
Pavlik harness.
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Conclusion
First in 1994 and then in 2008, we sent questionnaires to
multiple pediatric orthopedic institutions nationwide. We
requested data concerning children treated with the Pavlik
harness for developmental dysplasia of the hip. Our points
of interest were the reduction rate and incidence of avas-
cular necrosis of the femoral epiphysis, and in children
followed to skeletal maturity at age 14 years, the X-ray
outcomes. Reduction rates and the incidence of avascular
necrosis in the 2008 multicenter study were statistically
similar to the results collected in 1994. However, the rate
of acceptable outcome (Severin grade I ? II/total) in 2008
was statistically higher than that of 1994.
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